How To Get Zepbound: 5 Steps For Prescription, Coverage, Costs
A comprehensive guide to accessing Zepbound (tirzepatide), the FDA-approved medication for chronic weight management in adults with obesity or overweight conditions.
Zepbound (tirzepatide) is an FDA-approved injectable medication designed for chronic weight management in adults with obesity or overweight accompanied by weight-related conditions. Administered weekly under the skin, it mimics GLP-1 and GIP hormones to reduce appetite and promote significant weight loss when combined with diet and exercise.
What Is Zepbound?
Zepbound contains tirzepatide, the same active ingredient as Mounjaro, which is approved for type 2 diabetes. Unlike Mounjaro, Zepbound is specifically indicated for weight loss. The U.S. Food and Drug Administration (FDA) approved it on November 8, 2023, for adults with a body mass index (BMI) of 30 kg/m² or greater (obesity), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related comorbidity such as hypertension, dyslipidemia, or type 2 diabetes.
Approximately 70% of U.S. adults have obesity or overweight, increasing risks for cardiovascular disease and other issues. Clinical trials showed patients on the highest dose (15 mg weekly) lost an average of 18% body weight (without diabetes) or 12% (with diabetes) after 72 weeks, far surpassing placebo.
Zepbound works by activating GLP-1 and GIP receptors, reducing food intake, improving fat and sugar metabolism, and curbing hunger more effectively than GLP-1-only drugs like semaglutide (Wegovy).
Who Is Eligible for Zepbound?
Eligibility aligns with FDA criteria:
- Obesity: BMI ≥ 30 kg/m².
- Overweight: BMI ≥ 27 kg/m² with ≥1 weight-related condition (e.g., hypertension, type 2 diabetes, high cholesterol).
- Must commit to a reduced-calorie diet and increased physical activity.
- Not for cosmetic weight loss; intended for chronic management.
Calculate BMI using height and weight: BMI = weight (kg) / [height (m)]². Providers assess comorbidities via medical history, blood tests, and exams.
| BMI Category | Criteria | Example Weight (5’9″ height) |
|---|---|---|
| Obesity | BMI ≥30 | 203 lbs (92 kg) |
| Overweight | BMI ≥27 + comorbidity | 182 lbs (83 kg) |
Exclusions include personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
How to Talk to Your Doctor About Zepbound
Schedule an appointment with a primary care physician, endocrinologist, or obesity specialist. Prepare by:
- Listing symptoms, weight history, and past diet/exercise attempts.
- Noting comorbidities (e.g., blood pressure readings, A1C levels).
- Discussing family medical history and current medications.
- Asking: “Am I eligible for Zepbound? What results can I expect?”
Doctors may order labs (e.g., thyroid function, kidney tests) and calculate BMI. If eligible, they’ll prescribe starting at 2.5 mg weekly, titrating to 5-15 mg over 4-20 weeks to minimize side effects.
Steps to Get Prescribed Zepbound
- Consultation: See a licensed provider for evaluation.
- Prescription: Receive electronic or paper script for single-dose pens.
- Insurance Verification: Check coverage via provider or LillyDirect.
- Pharmacy Fulfillment: Use retail pharmacies or Lilly’s program for delivery.
- Initiate Treatment: Inject subcutaneously (abdomen, thigh, upper arm) weekly.
Telehealth platforms licensed in your state can prescribe if in-person not feasible.
How to Get Zepbound With Insurance
Coverage varies:
- Commercial Insurance: Many cover if criteria met; Lilly’s Savings Card reduces copay to $25/month (max $150 savings, 12 uses).
- Medicare/Medicaid: Often excludes weight loss drugs; check Part D plans.
- Prior Authorization: Requires BMI proof, comorbidities, lifestyle failure documentation.
List price ~$1,060/month; insured patients pay $25-$550. Use LillyDirect for coverage tools.
How to Get Zepbound Without Insurance
LillyDirect: Eli Lilly’s platform offers self-pay at ~$1,000-$1,100/month (varies by dose). Includes telehealth consults, home delivery, and 28-day supply pens. No prior authorization needed.
- Sign up at lillydirect.com.
- Complete virtual intake.
- Shipped discreetly; accepts HSA/FSA.
Compounding pharmacies offer tirzepatide analogs cheaper (~$300-$500/month) but lack FDA approval; use cautiously due to quality risks.
What Are the Side Effects of Zepbound?
Common (mostly mild, dose-dependent):
- Nausea, diarrhea, vomiting, constipation (20-30% patients).
- Abdominal pain, injection site reactions, fatigue.
- Burping, hair loss, GERD.
Serious (rare):
- Pancreatitis, gallbladder issues, hypoglycemia (with insulin/sulfonylureas).
- Acute kidney injury, diabetic retinopathy worsening.
- Allergic reactions, suicidal thoughts (monitor mental health).
Thyroid C-cell tumors in rats; contraindicated in MTC/MEN 2 history. Taper dose if discontinuing to avoid rebound.
What to Expect on Zepbound
Dosing: Start 2.5 mg weekly; increase gradually to 5/10/15 mg. Use new pen each week.
Weight Loss Timeline:
- Weeks 1-4: Appetite suppression, 2-5% loss.
- Weeks 5-20: Titration; 5-10% loss.
- 72 Weeks: Up to 18% average (SURMOUNT-1 trial, 231 lb starters).
Lifestyle integration key; expect GI adjustment period. Monitor blood sugar if diabetic.
How Much Does Zepbound Cost?
| Scenario | Monthly Cost |
|---|---|
| List Price | $1,060 |
| With Savings Card | $25 (insured) |
| LillyDirect Self-Pay | $1,000-$1,100 |
| Without Coverage | $550+ (copay assistance) |
Costs from Eli Lilly projections; varies by pharmacy/insurance.
Frequently Asked Questions (FAQs)
Who qualifies for Zepbound?
Adults with BMI ≥30 or ≥27 with weight-related conditions like hypertension or diabetes, per FDA.
Is Zepbound the same as Mounjaro?
Yes, both contain tirzepatide; Zepbound for weight loss, Mounjaro for diabetes (off-label use common).
How do I inject Zepbound?
Weekly subcutaneous injection in abdomen, thigh, or arm using prefilled pen. Rotate sites.
Does insurance cover Zepbound?
Many commercial plans do with prior auth; Medicare often excludes. Check LillyDirect.
Can I get Zepbound online?
Yes, via LillyDirect telehealth and delivery for eligible patients.
What if I miss a dose?
Take within 4 days; otherwise skip and resume schedule. Consult provider.
Is Zepbound safe long-term?
Trials up to 72 weeks show efficacy/safety; ongoing monitoring recommended.
References
- FDA Approves New Medication for Chronic Weight Management — U.S. Food and Drug Administration. 2023-11-08. https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management
- Zepbound is Approved by FDA for Obesity — Cardiometabolic Health Congress. 2023-11-08. https://www.cardiometabolichealth.org/article/zepbound-is-approved-by-fda-for-obesity/
Similar Articles
Read full bio of medha deb
